Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Medical
- Diagnostic
- Scientific & Technical Instruments
- Drugs
- Biotechnology
- Diagnostic Substances
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 29033
License Grant
Licensor and Licensee signed a world-wide License Agreement for Licensor's RapidSense technology, specifically for the purpose of making, using and offering for sale saliva tests for Drugs of Abuse.
License Property
RapidSense(R) is a patented technology – a one-step lateral flow test with unique features such as positive read indication for Drugs of Abuse, improved sensitivity, and the ability to read both large and small molecules. The rapid, disposable and point-of-care diagnostic technology is ideal for collection of either urine or oral fluids.
IPSCIO Record ID: 10350
License Grant
The Developer, government organization, of rapid saliva testing products, has enhanced its exclusive, worldwide license for the flow immunosensor technology (FIT).
Licensor grants to an exclusive right and license to practice the licensed invention throughout the United States and in the licensed territory in the field of saliva based human diagnostics and urine based testing for drugs of abuse and urine based testing for Methadone, Benzodiazapines Barbituates, Propoxyphene, Tricyclic Antidepressants and Anabolic Steroids.
License Property
FIT is a kinetic immunoassay that provides rapid diagnostic testing results onsite.
Licensor has an assignment of title to the invention disclosed and claimed in U.S. Patent Application Serial No. 07/486,024, and U.S. Patent No. 5,183,740 for Flow Immunosensor Method and Apparatus.
Field of Use
The agreement expands the field of use from drugs of abuse and anabolic steroids on urine samples to include all possible diagnostic uses for saliva.
IPSCIO Record ID: 1773
License Grant
The United States Navy, government organization, and the Company signed a ten-year license agreement covering the exclusive use by SAT of the USN’s technology for the five Drugs of Abuse and any other drugs that might be added to the National Institute of Drug Abuse list of drugs of abuse.
License Property
SAT for Drugs of Abuse detection utilizing the USN patent for flow immunosensor technology.
Field of Use
The rights granted apply to the drug industry.
IPSCIO Record ID: 3949
License Grant
We invested money into a newly formed 50/50 joint venture with another party, to bring to fruition R&D for innovative Point-of-care diagnostic tests.
License Property
The joint venture products will be focused on proprietary lateral flow and optics technologies (whereby a sample of saliva, urine, or whole blood moves across a solid platform to interact with a reagent to produce colorimetric or other changes that can be measured qualitatively or quantitatively) and Point-of-Care delivery of data through novel and inexpensive readers.
Field of Use
We intend to use lateral flow and optics intellectual property for the joint development of point of care diagnostic products for human, forensic and veterinary use.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
